LEADER 03745nam 2200733 a 450 001 9910451122903321 005 20210603222912.0 010 $a1-281-12554-7 010 $a9786611125547 010 $a0-226-23933-0 024 7 $a10.7208/9780226239330 035 $a(CKB)1000000000409947 035 $a(EBL)408354 035 $a(OCoLC)476228649 035 $a(SSID)ssj0000191521 035 $a(PQKBManifestationID)11168208 035 $a(PQKBTitleCode)TC0000191521 035 $a(PQKBWorkID)10184716 035 $a(PQKB)11622621 035 $a(MiAaPQ)EBC408354 035 $a(DE-B1597)535524 035 $a(OCoLC)1058278679 035 $a(DE-B1597)9780226239330 035 $a(Au-PeEL)EBL408354 035 $a(CaPaEBR)ebr10210020 035 $a(CaONFJC)MIL112554 035 $a(EXLCZ)991000000000409947 100 $a19991004d2000 uy 0 101 0 $aeng 135 $aurun#---|u||u 181 $ctxt 182 $cc 183 $acr 200 10$aLetters and orations$b[electronic resource] /$fCassandra Fedele ; edited and translated by Diana Robin 210 $aChicago $cUniversity of Chicago Press$d2000 215 $a1 online resource (211 p.) 225 1 $aOther voice in early modern Europe 300 $aDescription based upon print version of record. 311 0 $a0-226-23932-2 311 0 $a0-226-23931-4 320 $aIncludes bibliographical references (p. 167-174) and index. 327 $tFront matter --$tCONTENTS --$tIntroduction to the Series --$tAcknowledgments --$tEditor's Introduction --$tOne. Women Patrons --$tTwo. Family Members --$tThree. Princes and Courtiers --$tFour. Academics and Literary Friends --$tFive. Men of the Church --$tSix. Unknown Correspondents and Humanist Form Letters --$tSeven. The Public Lectures --$tBibliography --$tIndex 330 $aBy the end of the fifteenth century, Cassandra Fedele (1465-1558), a learned middle-class woman of Venice, was arguably the most famous woman writer and scholar in Europe. A cultural icon in her own time, she regularly corresponded with the king of France, lords of Milan and Naples, the Borgia pope Alexander VI, and even maintained a ten-year epistolary exchange with Queen Isabella and King Ferdinand of Spain that resulted in an invitation for her to join their court. Fedele's letters reveal the central, mediating role she occupied in a community of scholars otherwise inaccessible to women. Her unique admittance into this community is also highlighted by her presence as the first independent woman writer in Italy to speak publicly and, more importantly, the first to address philosophical, political, and moral issues in her own voice. Her three public orations and almost all of her letters, translated into English, are presented here for the first time. 410 0$aOther voice in early modern Europe. 606 $aSpeeches, addresses, etc., Latin (Medieval and modern)$zItaly$zVenice$vTranslations into English 606 $aAuthors, Latin (Medieval and modern)$zItaly$zVenice$vCorrespondence 606 $aHumanists$zItaly$zVenice$vCorrespondence 606 $aFeminists$zItaly$zVenice$vCorrespondence 607 $aItaly$xIntellectual life$y1268-1559$vSources 608 $aElectronic books. 615 0$aSpeeches, addresses, etc., Latin (Medieval and modern) 615 0$aAuthors, Latin (Medieval and modern) 615 0$aHumanists 615 0$aFeminists 676 $a875/.04 700 $aFedele$b Cassandra$f1465?-1558.$0997796 701 $aRobin$b Diana Maury$0158311 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910451122903321 996 $aLetters and orations$92288402 997 $aUNINA LEADER 01407aam 2200385I 450 001 9910710288203321 005 20250428213657.0 024 8 $aGOVPUB-C13-31931a42e86fd083198419f392a42871 035 $a(CKB)5470000002476401 035 $a(OCoLC)935499000 035 $a(EXLCZ)995470000002476401 100 $a20160121d1979 ua 0 101 0 $aeng 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aProtective coatings for steel structures $epart 1 - Survey of Air Force coating problems and development of an interim guide specification /$fP. G. Campbell; G. A. Sleater 210 1$aGaithersburg, MD :$cU.S. Dept. of Commerce, National Institute of Standards and Technology,$d1979. 215 $a1 online resource 225 1 $aNBSIR ;$v79-1773 300 $a1979. 300 $aContributed record: Metadata reviewed, not verified. Some fields updated by batch processes. 300 $aTitle from PDF title page. 320 $aIncludes bibliographical references. 517 $aProtective coatings for steel structures 700 $aCampbell$b P. G$01393532 701 $aSleater$b Gerald A$01392208 712 02$aUnited States.$bNational Bureau of Standards. 801 0$bNBS 801 1$bNBS 801 2$bGPO 906 $aBOOK 912 $a9910710288203321 996 $aProtective coatings for steel structures$94372068 997 $aUNINA LEADER 03070nam 2200757z- 450 001 9910557494603321 005 20220111 035 $a(CKB)5400000000042885 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76581 035 $a(oapen)doab76581 035 $a(EXLCZ)995400000000042885 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNewborn Screening for Pompe Disease 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (146 p.) 311 08$a3-0365-0580-6 311 08$a3-0365-0581-4 330 $aPompe disease, also known as acid maltase deficiency or acid alpha-glucosidase deficiency, in its most severe form results in a rapidly progressive, neonatal-onset skeletal and cardiomyopathy, leading to early infantile death without treatment. The development of treatment with recombinant enzyme replacement therapy radically transformed the clinical trajectory of those affected, enabling long-term ventilator-free survival with resolution of cardiomyopathy. These positive clinical outcomes resulted in the implementation of newborn screening programs for Pompe disease across the world. This Special Issue highlights some of the experiences of Pompe screening programs worldwide and discusses public policy and ethical issues elicited by presymptomatic screening for Pompe disease. 606 $aTechnology: general issues$2bicssc 610 $aacid ?-glucosidase 610 $aalpha glucosidase 610 $ac.-32-13T& 610 $aCalifornia 610 $across-reactive immunologic material 610 $adiagnosis 610 $adried blood spots 610 $aenzyme replacement therapy 610 $afollow-up 610 $aG 610 $aGAA sequencing 610 $agenotype-phenotype correlation 610 $agt 610 $aimmune modulation therapy 610 $ainfantile onset Pompe disease 610 $ainfantile-onset 610 $ainfantile-onset Pompe disease 610 $alate onset Pompe disease 610 $alate-onset 610 $alysosomal storage diseases 610 $an/a 610 $anew disorders implementation 610 $anewborn screening 610 $anext generation sequencing 610 $apatient perspective 610 $aPompe disease 610 $aPompe disease diagnostics testing 610 $apresymptomatic 610 $apseudodeficiency 610 $atreatment and follow-up 610 $avariant cut-off 615 7$aTechnology: general issues 700 $aHwu$b Wuh-Liang$4edt$01302774 702 $aChien$b Yin-Hsiu$4edt 702 $aWang$b Raymond$4edt 702 $aHwu$b Wuh-Liang$4oth 702 $aChien$b Yin-Hsiu$4oth 702 $aWang$b Raymond$4oth 906 $aBOOK 912 $a9910557494603321 996 $aNewborn Screening for Pompe Disease$93026551 997 $aUNINA